It was also reported that MALAT1 downregulation may influence MS course through the modulation of pro-inflammatory Th1 and Th17 cells, leading to a decrease in T-regs differentiation as well as an increase in Th1 and Th17 inflammatory phenotypes [60]. The gene discussed is MALAT1; the disease is myeloid sarcoma.